Event Report
1. Name of participated organization
Mitsubishi UFJ Research and Consulting (MURC)

2. Certification numberS058

3. Name of co-organizer(s)Japan Anti-Tuberculosis Association (JATA), Stop TB Partnership (STBP), Stop TB
Partnership Japan (STBPJ), Results Japan, International AIDS Vaccine Initiative (IAVI),
United Nations Development Programme (UNDP) and Japan International Cooperation
Agency (JICA)

4. Your seminar date, time
14:30-17:00, 28th Aug 2019

5. Venue and state room number (ex. F202)
Annex F202, Pacifico Yokohama

6. Number of participants to your seminar/symposium
58

7. Ratio of gender among participants (estimate)
Male: 38, Female: 20

8. Nationality among participants (estimate)
Japanese: 49, Overseas: 9

9. Evaluation as an event organizer (including points to look back)It was a great opportunity to set this event at TICAD7 where one of the main topics
is “innovation”. Through this event, co-host organizers and audiences shared theimportance of accelerating digitalization of TB response, to bring innovations toward theglobal goal of ending TB by 2030. In addition, we pointed out some of the current
challenges in implementation and discussing these in this event was also valuable toreflect the points on practical operations at each organization.
110. Requests, suggestion and problem presentations from organizers
The front screen should be set much higher not to shed presentation on thespeakers/panelists (stages at the exhibition hall looks OK)

11. About seminar/symposium① Name of the Event
Digital Health and Data-Driven Innovation in TB Response② Name of the main speakers and panelists
Michikazu Koshiba, Head of Center on Global Health Architecture/GeneralManager of Social Impact Partnership Business dept., MURC

Lucica Ditiu, Executive Director, STBPJacqueline Huh, Head of Strategic Initiatives & Innovative Financing, STBPMasaharu Morita, Global marketing & new business manager, medical division,Fujifilm corporation

Kagiso Ndlovu, CEO, Ultimate Informatics



Dereck Tait, Senior Medical Director, TB Program, IAVI

Stephanie Mikulasek, Foreign Service Officer, Deputy Director of the Office ofDevelopment Cooperation, USAID

George Sabblah, Head of Safety Monitoring Department, Food and Drugs
Authority of Ghana as a representative of ADPToru Mori, Executive Representative, STBJ, Director Emeritus, JATA

③ Name of the media
N/A④ Lists of articles publicized in media
N/A⑤ Outline of the Event
The purpose of this event is to highlight the latest examples of digital
health/data innovation in TB response including prevention, diagnosis, care andtreatment. As the opening of the session, Dr. Lucica Ditiu from Stop TB Partnershipmade a remark. She strongly emphasized the importance of digitalization in TB
response to treat 40 million TB patients by 2022 and achieve the global goal of2

ending TB by 2030 while many parts of TB control are still heavily relied on paperbased data.
Following the remarks, a panel discussion of experts was held to share
their opinions and challenges in utilizing digital technologies and data managementwith a moderation by Ms. Jacqueline Huh (STBP). From vaccine perspective, Dr.
Tait pointed out that reliable digitalized data is very effective to make the vaccine
study shorter, smaller and less costly. Mr. Morita from Fujifilm introduced their AIadded X-ray diagnostics which is particularly effective for initial screening. The AI,
educated by result of CT diagnosis, identifies the possibility of being infected to TB
from X-ray images. The panel also discussed the African countries’ initiatives on
digital health: the one is a TB patients’ contact tracing system based on mobile
network in Botswana, presented by Mr. Kagiso Ndlovu. The other is online datamanagement system developed in Ghana, where one of the ADP focus countries.
Mr. George Sabblah (ADP) presented a successful example of the digitization ofpharmacovigilance that has been used in Ghana to improve the early detection,
reporting, and management of adverse drug reactions.
Ms. Mikulasek from USAID illustrated their unique and innovative TB
program “Global Accelerator to End TB” to catalyze investments across different
sectors, especially working on improving patients’ and providers’ access to thenecessary information.
There were many questions to the panelists regarding cost-strategy,
connectivity and interoperability in implementing digitalization of TB control from theaudiences. Lastly, Dr. Toru Mori concluded the session with this comment: “IT isalmost ready for the real practices in TB control in developing countries and unitedefforts between developed and developing countries, high-TB burden and low-TB
burden countries are important to make them come true.”
12．About Exhibition① Name of the Exhibition② Name of the media

N/A③ Lists of articles publicated in media
13. Record photos
Welcome Comment by MURC

Opening Remark by Dr. Ditiu

3

Panel Discussion by Experts

Closing Remark by Dr. Mori

14. Related Documents
N/A4